Hajela et al., 2015 - Google Patents
Gut microbiome, gut function, and probiotics: Implications for healthHajela et al., 2015
View PDF- Document ID
- 13442667032359567294
- Author
- Hajela N
- Ramakrishna B
- Nair G
- Abraham P
- Gopalan S
- Ganguly N
- Publication year
- Publication venue
- Indian Journal of Gastroenterology
External Links
Snippet
New insights from a rapidly developing field of research have ushered in a new era of understanding of the complexity of host-microbe interactions within the human body. The paradigm shift from culturing to metagenomics has provided an insight into the complex …
- 230000000529 probiotic 0 title abstract description 187
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hajela et al. | Gut microbiome, gut function, and probiotics: Implications for health | |
| Ballini et al. | About functional foods: The probiotics and prebiotics state of art | |
| Al-Fakhrany et al. | Next-generation probiotics: the upcoming biotherapeutics | |
| Gomaa | Human gut microbiota/microbiome in health and diseases: a review | |
| Nabavi-Rad et al. | The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management | |
| Garcia-Gonzalez et al. | Health-promoting role of Lactiplantibacillus plantarum isolated from fermented foods | |
| Gallo et al. | Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate | |
| Capurso | Thirty years of Lactobacillus rhamnosus GG: a review | |
| Vyas et al. | Probiotics, prebiotics, and synbiotics: gut and beyond | |
| Markowiak et al. | Effects of probiotics, prebiotics, and synbiotics on human health | |
| Scaldaferri et al. | Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility | |
| Doron et al. | Probiotics: their role in the treatment and prevention of disease | |
| Pandey et al. | Probiotics, prebiotics and synbiotics-a review | |
| Ceapa et al. | Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health | |
| Varankovich et al. | Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases | |
| Verna et al. | Use of probiotics in gastrointestinal disorders: what to recommend? | |
| JP2022000040A (en) | Use of pasteurized akkermansia for treating metabolic disorders | |
| CN109069552B (en) | Bifidobacterium longum for the treatment of obesity and related metabolic disorders | |
| JP2020532515A (en) | Methods and compositions for the treatment of microbiome-related disorders | |
| Xu et al. | Effective regulation of gut microbiota with probiotics and prebiotics may prevent or alleviate COVID-19 through the gut-lung axis | |
| CN103491969A (en) | Synbiotic compositions for restoration and reconstitution of gut microbiota | |
| CN102711778A (en) | Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria | |
| Liu et al. | Bifidobacterium lactis ameliorates the risk of food allergy in Chinese children by affecting relative percentage of Treg and Th17 cells | |
| CA2842379A1 (en) | Production and use of bacterial histamine | |
| Orlando et al. | RETRACTED ARTICLE: Intestinal Microbiota, Probiotics and Human Gastrointestinal Cancers |